西方人群胃癌腹腔镜与开腹胃切除术的肿瘤外科质量与结局比较
基于美国国家癌症数据库13,538例成人胃腺癌患者,比较腹腔镜与开腹胃切除术的肿瘤外科质量和结局。腹腔镜组淋巴结检出数更优、住院时间更短、非计划再入院率更低,R1切缘率、30天和90天死亡率无显著差异。中位生存期腹腔镜组44.8个月 vs 开腹组40.2个月(p=0.804),长期结局相当。
要点
- 腹腔镜胃切除术淋巴结检出数更优、住院时间更短、再入院率更低。
- R1切缘率、30天和90天死亡率两种术式无显著差异。
- 中位生存期腹腔镜组44.8个月与开腹组40.2个月相当(p=0.804)。
核心结论
- 腹腔镜胃切除术治疗胃癌安全,住院时间更短、再入院率更低,肿瘤外科质量参数相当或更优。
- 西方人群数据显示腹腔镜与开腹胃切除术可获得等效的长期生存结局。
研究设计与样本
- 基于美国国家癌症数据库的回顾性人群研究,纳入13,538例资料完整的成人胃腺癌患者。
- 采用逻辑回归分析切缘状态、30天和90天死亡率及30天再入院率,线性回归分析住院时间和淋巴结检出数。
- 采用Kaplan-Meier法评估中位生存期,Cox多因素回归校正混杂因素并识别影响生存的因素。
主要发现
- 腹腔镜组在淋巴结检出数、住院时间和非计划再入院率方面显著优于开腹组。
- 手术方式对R1切缘率、30天死亡率或90天死亡率无显著影响。
- 腹腔镜组与开腹组中位生存期分别为44.8个月和40.2个月(p=0.804)。
临床怎么用
- 在西方人群中,腹腔镜胃切除术可作为胃癌的安全手术选择,不牺牲肿瘤学质量。
- 腹腔镜手术可能缩短住院时间并降低再入院率,有利于围术期资源利用。
- 长期生存与开腹手术相当,支持在合适患者中推广应用腹腔镜胃切除术。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While studies have reported improved morbidity of laparoscopic (LG) compared with open gastrectomy (OG), it remains unclear whether comparable oncologic outcomes can be achieved. This study aims at comparing not only short-term outcomes, including 30- and 90-day mortality, but also survival of LG vs OG. METHODS: The National Cancer Database was searched for adult patients with histologically proven gastric cancer and complete information regarding M0 disease, tumor size, differentiation grade, T stage, nodal status, comorbidities, type of hospital, hospital stay, type of surgery, oncological treatment and survival data were included. Logistic regression analyses were performed to analyze margin status, 30- and 90-day mortality, and 30-day re-admission rate. Linear regression was performed for length of hospital stay and lymph node yield. Kaplan-Meier survival analyses were performed to evaluate median survival. Cox multivariable regression models were created to correct for confounders and identify factors affecting survival. RESULTS: A query of the National Cancer Database identified 13,538 patients with complete dataset. A significant regression equation favoring LG for lymph node yield, hospital stay, and unplanned re-admission rate was identified. There was no significant effect of surgical approach on R1 margin rate, 30-day mortality, or 90-day mortality. Median survival was comparable between LG and OG (44.8 vs 40.2 months, p = 0.804). CONCLUSION: LG offers a safe surgical approach to gastric cancer with shorter hospital stay and lower re-admission rates than OG, and also similar and sometimes improved operative oncologic quality parameters (margin, lymph node yield). More importantly, this Western series demonstrates that equivalent long-term outcomes of LG vs. OG are being achieved.
引用
- Salehi O, Vega EA, Kutlu OC, et al. Western population-based study of oncologic surgical quality and outcomes of laparoscopic versus open gastrectomy for gastric adenocarcinoma. Surg Endosc. 2020. PMID: 32909213. doi:10.1007/s00464-020-07959-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。